The company said its annual meeting of shareholders was held on April 24, 2024, and that 256,548,480 of the 283,647,404 shares entitled to vote, or 90.44%, were represented in person or by proxy.

1. 01

   The company said its annual meeting of shareholders was held on April 24, 2024, and that 256,548,480 of the 283,647,404 shares entitled to vote, or 90.44%, were represented in person or by proxy.

2. 02

   The Cigna Group said the 12 director nominees named in the 2024 Proxy Statement were elected to one-year terms. David M. Cordani received 222,758,788 votes for and 12,902,745 votes against.

3. 03

   Cigna said shareholders cast 197,173,863 votes for and 39,200,994 votes against the advisory approval of executive compensation. For the ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2024, there were 237,481,094 votes for and 18,876,505 votes against.

4. 04

   The company said the shareholder proposal to improve the shareholder right to call a special shareholder meeting received 114,022,412 votes for and 119,621,641 votes against. The shareholder proposal to report to shareholders on risks created by the company's diversity, equity, and inclusion efforts received 3,720,474 votes for and 231,360,098 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.